K-ras and B-raf mutations and antiEGFr antibody therapy

Details for Australian Patent Application No. 2008226808 (hide)

Owner Amgen Inc.

Inventors Bardelli, Alberto; Siena, Salvatore

Agent Shelston IP

Pub. Number AU-A-2008226808

PCT Pub. Number WO2008/112274

Priority 60/906,976 13.03.07 US

Filing date 11 March 2008

Wipo publication date 18 September 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

8 October 2009 PCT application entered the National Phase

  PCT publication WO2008/112274 Priority application(s): WO2008/112274

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008226814-Substituted heterocycle fused gammacarbolines synthesis

2008226803-K-ras mutations and anti-EGFr antibody therapy